Folate improves endothelial function in coronary artery disease: An effect mediated by reduction of intracellular superoxide?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 7, 2001, Pages 1196-1202

  Doshi, Sagar N ^a   McDowell, Ian F W ^a   Moat, Stuart J ^a   Lang, Derek ^a   Newcombe, Robert G ^a   Kredan, Mahmud B ^a   Lewis, Malcolm J ^a   Goodfellow, Jonathan ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

5 methyltetrahydrofolate; Coronary artery disease; Endothelial function; Folic acid; Homocysteine

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTIOXIDANT; BIOCHEMICAL MARKER; FOLIC ACID; HOMOCYSTEINE; MALONALDEHYDE; PLACEBO; SUPEROXIDE; TETRAHYDROBIOPTERIN;

ADULT; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTERY ENDOTHELIUM; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CELL CULTURE; CELL FUNCTION; CELL LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035721992     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0701.092000     Document Type: Article

References (43)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
2. Homocysteine and cardiovascular risk
3. Lowering blood homocysteine with folic acid based supplements, meta-analysis of randomised trials
4. Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12
5. The natural history of vascular disease in homocystinuria and the effects of treatment
6. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: Effects of homocysteine-lowering therapy
7. Clinical implications of plasma homocysteine measurement in cardiovascular disease
8. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial
9. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease: A prospective cohort study
10. The pathogenesis of atherosclerosis: A perspective for the 1990s
11. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
12. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults
13. The oxidant stress of hyperhomocyst(e)inemia
14. Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine
15. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease
16. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
17. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia
18. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypereholesterolemia
19. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia
20. Measurement of 5-methyltetrahydrofolic acid in man by high-performance liquid chromatography
21. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors
22. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates
23. The effect of folic acid on the homocysteine metabolism in human umbilical vein endothelial cells (HUVECs)
24. Inhibition of inositol 1,4,5-trisphosphate formation by cyclic GMP in cultured aortic endothelial cells of the pig
25. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: Role for superoxide anions
26. The two-period cross-over clinical trial
27. Normal ranges for brachial artery flow-mediated dilatation: A non-invasive ultrasound test of arterial endothelial function
28. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia
29. Homocysteine and endothelial function
30. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease: Homocysteine and peripheral vascular disease
31. Hyperhomocysteinemia and oxidative stress: Time for a reality check?
32. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans
33. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy
34. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
35. Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men
36. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels
37. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population
38. Hyperhomocysteinemia following oral methionine load is associated with increased lipid peroxidation
39. Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading
40. Folic acid reverts dysfunction of endothelial nitric oxide synthase
41. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
42. Some metabolic relationships between biopterin and folate: Implications for the "methyl trap hypothesis."
43. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis